Global Recombinant Human Endostatin Market Research Report 2016

Global Recombinant Human Endostatin Market Research Report 2016

1 Recombinant Human Endostatin Market Overview

1.1 Product Overview and Scope of Recombinant Human Endostatin

1.2 Recombinant Human Endostatin Segment by Type

1.2.1 Global Production Market Share of Recombinant Human Endostatin by Type in 2015

1.2.2 Type I

1.2.3 Type II

1.2.4 Type III

1.3 Recombinant Human Endostatin Segment by Application

1.3.1 Recombinant Human Endostatin Consumption Market Share by Application in 2015

1.3.2 Application 1

1.3.3 Application 2

1.3.4 Application 3

1.4 Recombinant Human Endostatin Market by Region

1.4.1 North America Status and Prospect (2011-2021)

1.4.2 Europe Status and Prospect (2011-2021)

1.4.3 China Status and Prospect (2011-2021)

1.4.4 Japan Status and Prospect (2011-2021)

1.4.5 Southeast Asia Status and Prospect (2011-2021)

1.4.6 India Status and Prospect (2011-2021)

1.5 Global Market Size (Value) of Recombinant Human Endostatin (2011-2021)

2 Global Recombinant Human Endostatin Market Competition by Manufacturers

2.1 Global Recombinant Human Endostatin Production and Share by Manufacturers (2015 and 2016)

2.2 Global Recombinant Human Endostatin Revenue and Share by Manufacturers (2015 and 2016)

2.3 Global Recombinant Human Endostatin Average Price by Manufacturers (2015 and 2016)

2.4 Manufacturers Recombinant Human Endostatin Manufacturing Base Distribution, Sales Area and Product Type

2.5 Recombinant Human Endostatin Market Competitive Situation and Trends

2.5.1 Recombinant Human Endostatin Market Concentration Rate

2.5.2 Recombinant Human Endostatin Market Share of Top 3 and Top 5 Manufacturers

2.5.3 Mergers & Acquisitions, Expansion

3 Global Recombinant Human Endostatin Production, Revenue (Value) by Region (2011-2016)

3.1 Global Recombinant Human Endostatin Production and Market Share by Region (2011-2016)

3.2 Global Recombinant Human Endostatin Revenue (Value) and Market Share by Region (2011-2016)

3.3 Global Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2011-2016)

3.4 North America Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2011-2016)

3.5 Europe Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2011-2016)

3.6 China Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2011-2016)

3.7 Japan Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2011-2016)

3.8 Southeast Asia Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2011-2016)

3.9 India Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2011-2016)

4 Global Recombinant Human Endostatin Supply (Production) , Consumption, Export, Import by Regions (2011-2016)

4.1 Global Recombinant Human Endostatin Consumption by Regions (2011-2016)

4.2 North America Recombinant Human Endostatin Production, Consumption, Export, Import by Regions (2011-2016)

4.3 Europe Recombinant Human Endostatin Production, Consumption, Export, Import by Regions (2011-2016)

4.4 China Recombinant Human Endostatin Production, Consumption, Export, Import by Regions (2011-2016)

4.5 Japan Recombinant Human Endostatin Production, Consumption, Export, Import by Regions (2011-2016)

4.6 Southeast Asia Recombinant Human Endostatin Production, Consumption, Export, Import by Regions (2011-2016)

4.7 India Recombinant Human Endostatin Production, Consumption, Export, Import by Regions (2011-2016)

5 Global Recombinant Human Endostatin Production, Revenue (Value) , Price Trend by Type

5.1 Global Recombinant Human Endostatin Production and Market Share by Type (2011-2016)

5.2 Global Recombinant Human Endostatin Revenue and Market Share by Type (2011-2016)

5.3 Global Recombinant Human Endostatin Price by Type (2011-2016)

5.4 Global Recombinant Human Endostatin Production Growth by Type (2011-2016)

6 Global Recombinant Human Endostatin Market Analysis by Application

6.1 Global Recombinant Human Endostatin Consumption and Market Share by Application (2011-2016)

6.2 Global Recombinant Human Endostatin Consumption Growth Rate by Application (2011-2016)

6.3 Market Drivers and Opportunities

6.3.1 Potential Applications

6.3.2 Emerging Markets/Countries

7 Global Recombinant Human Endostatin Manufacturers Profiles/Analysis

7.1 Pfizer

7.1.1 Company Basic Information, Manufacturing Base and Its Competitors

7.1.2 Recombinant Human Endostatin Product Type, Application and Specification

7.1.2.1 Type I

7.1.2.2 Type II

7.1.3 Pfizer Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2015 and 2016)

7.1.4 Main Business/Business Overview

7.2 Allergan

7.2.1 Company Basic Information, Manufacturing Base and Its Competitors

7.2.2 Recombinant Human Endostatin Product Type, Application and Specification

7.2.2.1 Type I

7.2.2.2 Type II

7.2.3 Allergan Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2015 and 2016)

7.2.4 Main Business/Business Overview

7.3 Alnylam Pharmaceuticals

7.3.1 Company Basic Information, Manufacturing Base and Its Competitors

7.3.2 Recombinant Human Endostatin Product Type, Application and Specification

7.3.2.1 Type I

7.3.2.2 Type II

7.3.3 Alnylam Pharmaceuticals Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2015 and 2016)

7.3.4 Main Business/Business Overview

7.4 Amgen

7.4.1 Company Basic Information, Manufacturing Base and Its Competitors

7.4.2 Recombinant Human Endostatin Product Type, Application and Specification

7.4.2.1 Type I

7.4.2.2 Type II

7.4.3 Amgen Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2015 and 2016)

7.4.4 Main Business/Business Overview

7.5 Angstrom Pharmaceuticals

7.5.1 Company Basic Information, Manufacturing Base and Its Competitors

7.5.2 Recombinant Human Endostatin Product Type, Application and Specification

7.5.2.1 Type I

7.5.2.2 Type II

7.5.3 Angstrom Pharmaceuticals Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2015 and 2016)

7.5.4 Main Business/Business Overview

7.6 Acceleron Pharma

7.6.1 Company Basic Information, Manufacturing Base and Its Competitors

7.6.2 Recombinant Human Endostatin Product Type, Application and Specification

7.6.2.1 Type I

7.6.2.2 Type II

7.6.3 Acceleron Pharma Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2015 and 2016)

7.6.4 Main Business/Business Overview

7.7 Biocon

7.7.1 Company Basic Information, Manufacturing Base and Its Competitors

7.7.2 Recombinant Human Endostatin Product Type, Application and Specification

7.7.2.1 Type I

7.7.2.2 Type II

7.7.3 Biocon Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2015 and 2016)

7.7.4 Main Business/Business Overview

7.8 Bionomics

7.8.1 Company Basic Information, Manufacturing Base and Its Competitors

7.8.2 Recombinant Human Endostatin Product Type, Application and Specification

7.8.2.1 Type I

7.8.2.2 Type II

7.8.3 Bionomics Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2015 and 2016)

7.8.4 Main Business/Business Overview

7.9 CASI Pharmaceuticals

7.9.1 Company Basic Information, Manufacturing Base and Its Competitors

7.9.2 Recombinant Human Endostatin Product Type, Application and Specification

7.9.2.1 Type I

7.9.2.2 Type II

7.9.3 CASI Pharmaceuticals Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2015 and 2016)

7.9.4 Main Business/Business Overview

7.10 Celgene Corporation

7.10.1 Company Basic Information, Manufacturing Base and Its Competitors

7.10.2 Recombinant Human Endostatin Product Type, Application and Specification

7.10.2.1 Type I

7.10.2.2 Type II

7.10.3 Celgene Corporation Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2015 and 2016)

7.10.4 Main Business/Business Overview

7.11 Enzon Pharmaceuticals

7.12 Five Prime Therapeutics

7.13 Fujifilm Kyowa Kirin Biologics

7.14 Genentech

7.15 Genexine

7.16 Hetero Drugs

7.17 ImClone Systems

7.18 Intas Pharmaceuticals

7.19 Kyowa Hakko Kirin

7.20 Levolta Pharmaceuticals

7.21 Mabtech

7.22 Marsala Biotech

7.23 Neumedicines

7.24 Novartis

7.25 Oncobiologics

7.26 Onyx Pharmaceuticals

8 Recombinant Human Endostatin Manufacturing Cost Analysis

8.1 Recombinant Human Endostatin Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.2.1 Raw Materials

8.2.2 Labor Cost

8.2.3 Manufacturing Expenses

8.3 Manufacturing Process Analysis of Recombinant Human Endostatin

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Recombinant Human Endostatin Industrial Chain Analysis

9.2 Upstream Raw Materials Sourcing

9.3 Raw Materials Sources of Recombinant Human Endostatin Major Manufacturers in 2015

9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders

10.1 Marketing Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.1.3 Marketing Channel Development Trend

10.2 Market Positioning

10.2.1 Pricing Strategy

10.2.2 Brand Strategy

10.2.3 Target Client

10.3 Distributors/Traders List

11 Market Effect Factors Analysis

11.1 Technology Progress/Risk

11.1.1 Substitutes Threat

11.1.2 Technology Progress in Related Industry

11.2 Consumer Needs/Customer Preference Change

11.3 Economic/Political Environmental Change

12 Global Recombinant Human Endostatin Market Forecast (2016-2021)

12.1 Global Recombinant Human Endostatin Production, Revenue Forecast (2016-2021)

12.2 Global Recombinant Human Endostatin Production, Consumption Forecast by Regions (2016-2021)

12.3 Global Recombinant Human Endostatin Production Forecast by Type (2016-2021)

12.4 Global Recombinant Human Endostatin Consumption Forecast by Application (2016-2021)

12.5 Recombinant Human Endostatin Price Forecast (2016-2021)

13 Research Findings and Conclusion

14 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

China Disclaimer

Figure Picture of Recombinant Human Endostatin

Figure Global Production Market Share of Recombinant Human Endostatin by Type in 2015

Figure Product Picture of Type I

Table Major Manufacturers of Type I

Figure Product Picture of Type II

Table Major Manufacturers of Type II

Figure Product Picture of Type III

Table Major Manufacturers of Type III

Table Recombinant Human Endostatin Consumption Market Share by Application in 2015

Figure Application 1 Examples

Figure Application 2 Examples

Figure Application 3 Examples

Figure North America Recombinant Human Endostatin Revenue (Million USD) and Growth Rate (2011-2021)

Figure Europe Recombinant Human Endostatin Revenue (Million USD) and Growth Rate (2011-2021)

Figure China Recombinant Human Endostatin Revenue (Million USD) and Growth Rate (2011-2021)

Figure Japan Recombinant Human Endostatin Revenue (Million USD) and Growth Rate (2011-2021)

Figure Southeast Asia Recombinant Human Endostatin Revenue (Million USD) and Growth Rate (2011-2021)

Figure India Recombinant Human Endostatin Revenue (Million USD) and Growth Rate (2011-2021)

Figure Global Recombinant Human Endostatin Revenue (Million UDS) and Growth Rate (2011-2021)

Table Global Recombinant Human Endostatin Production of Key Manufacturers (2015 and 2016)

Table Global Recombinant Human Endostatin Production Share by Manufacturers (2015 and 2016)

Figure 2015 Recombinant Human Endostatin Production Share by Manufacturers

Figure 2016 Recombinant Human Endostatin Production Share by Manufacturers

Table Global Recombinant Human Endostatin Revenue (Million USD) by Manufacturers (2015 and 2016)

Table Global Recombinant Human Endostatin Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Global Recombinant Human Endostatin Revenue Share by Manufacturers

Table 2016 Global Recombinant Human Endostatin Revenue Share by Manufacturers

Table Global Market Recombinant Human Endostatin Average Price of Key Manufacturers (2015 and 2016)

Figure Global Market Recombinant Human Endostatin Average Price of Key Manufacturers in 2015

Table Manufacturers Recombinant Human Endostatin Manufacturing Base Distribution and Sales Area

Table Manufacturers Recombinant Human Endostatin Product Type

Figure Recombinant Human Endostatin Market Share of Top 3 Manufacturers

Figure Recombinant Human Endostatin Market Share of Top 5 Manufacturers

Table Global Recombinant Human Endostatin Production by Regions (2011-2016)

Figure Global Recombinant Human Endostatin Production and Market Share by Regions (2011-2016)

Figure Global Recombinant Human Endostatin Production Market Share by Regions (2011-2016)

Figure 2015 Global Recombinant Human Endostatin Production Market Share by Regions

Table Global Recombinant Human Endostatin Revenue by Regions (2011-2016)

Table Global Recombinant Human Endostatin Revenue Market Share by Regions (2011-2016)

Table 2015 Global Recombinant Human Endostatin Revenue Market Share by Regions

Table Global Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2011-2016)

Table North America Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2011-2016)

Table Europe Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2011-2016)

Table China Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2011-2016)

Table Japan Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2011-2016)

Table Southeast Asia Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2011-2016)

Table India Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2011-2016)

Table Global Recombinant Human Endostatin Consumption Market by Regions (2011-2016)

Table Global Recombinant Human Endostatin Consumption Market Share by Regions (2011-2016)

Figure Global Recombinant Human Endostatin Consumption Market Share by Regions (2011-2016)

Figure 2015 Global Recombinant Human Endostatin Consumption Market Share by Regions

Table North America Recombinant Human Endostatin Production, Consumption, Import & Export (2011-2016)

Table Europe Recombinant Human Endostatin Production, Consumption, Import & Export (2011-2016)

Table China Recombinant Human Endostatin Production, Consumption, Import & Export (2011-2016)

Table Japan Recombinant Human Endostatin Production, Consumption, Import & Export (2011-2016)

Table Southeast Asia Recombinant Human Endostatin Production, Consumption, Import & Export (2011-2016)

Table India Recombinant Human Endostatin Production, Consumption, Import & Export (2011-2016)

Table Global Recombinant Human Endostatin Production by Type (2011-2016)

Table Global Recombinant Human Endostatin Production Share by Type (2011-2016)

Figure Production Market Share of Recombinant Human Endostatin by Type (2011-2016)

Figure 2015 Production Market Share of Recombinant Human Endostatin by Type

Table Global Recombinant Human Endostatin Revenue by Type (2011-2016)

Table Global Recombinant Human Endostatin Revenue Share by Type (2011-2016)

Figure Production Revenue Share of Recombinant Human Endostatin by Type (2011-2016)

Figure 2015 Revenue Market Share of Recombinant Human Endostatin by Type

Table Global Recombinant Human Endostatin Price by Type (2011-2016)

Figure Global Recombinant Human Endostatin Production Growth by Type (2011-2016)

Table Global Recombinant Human Endostatin Consumption by Application (2011-2016)

Table Global Recombinant Human Endostatin Consumption Market Share by Application (2011-2016)

Figure Global Recombinant Human Endostatin Consumption Market Share by Application in 2015

Table Global Recombinant Human Endostatin Consumption Growth Rate by Application (2011-2016)

Figure Global Recombinant Human Endostatin Consumption Growth Rate by Application (2011-2016)

Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Pfizer Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2011-2016)

Figure Pfizer Recombinant Human Endostatin Market Share (2011-2016)

Table Allergan Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Allergan Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2011-2016)

Figure Allergan Recombinant Human Endostatin Market Share (2011-2016)

Table Alnylam Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Alnylam Pharmaceuticals Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2011-2016)

Figure Alnylam Pharmaceuticals Recombinant Human Endostatin Market Share (2011-2016)

Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Amgen Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2011-2016)

Figure Amgen Recombinant Human Endostatin Market Share (2011-2016)

Table Angstrom Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Angstrom Pharmaceuticals Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2011-2016)

Figure Angstrom Pharmaceuticals Recombinant Human Endostatin Market Share (2011-2016)

Table Acceleron Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Acceleron Pharma Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2011-2016)

Figure Acceleron Pharma Recombinant Human Endostatin Market Share (2011-2016)

Table Biocon Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Biocon Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2011-2016)

Figure Biocon Recombinant Human Endostatin Market Share (2011-2016)

Table Bionomics Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Bionomics Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2011-2016)

Figure Bionomics Recombinant Human Endostatin Market Share (2011-2016)

Table CASI Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table CASI Pharmaceuticals Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2011-2016)

Figure CASI Pharmaceuticals Recombinant Human Endostatin Market Share (2011-2016)

Table Celgene Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Celgene Corporation Recombinant Human Endostatin Production, Revenue, Price and Gross Margin (2011-2016)

Figure Celgene Corporation Recombinant Human Endostatin Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Recombinant Human Endostatin

Figure Manufacturing Process Analysis of Recombinant Human Endostatin

Figure Recombinant Human Endostatin Industrial Chain Analysis

Table Raw Materials Sources of Recombinant Human Endostatin Major Manufacturers in 2015

Table Major Buyers of Recombinant Human Endostatin

Table Distributors/Traders List

Figure Global Recombinant Human Endostatin Production and Growth Rate Forecast (2016-2021)

Figure Global Recombinant Human Endostatin Revenue and Growth Rate Forecast (2016-2021)

Table Global Recombinant Human Endostatin Production Forecast by Regions (2016-2021)

Table Global Recombinant Human Endostatin Consumption Forecast by Regions (2016-2021)

Table Global Recombinant Human Endostatin Production Forecast by Type (2016-2021)

Table Global Recombinant Human Endostatin Consumption Forecast by Application (2016-2021)